As the Trump administration erodes U.S. infrastructure supporting infectious disease vaccines, mRNA heavyweight Moderna plans ...
GSK is set to buy Rapt Therapeutics in a $2.2 billion deal. AstraZeneca agreed to a $630 million pact to secure remaining rights to armored CAR-T from AbelZeta. Bristol Myers Squibb signed a deal with ...
Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...
Astellas' CEO said he doesn't want to make acquisitions simply to fill a revenue gap. Takeda is preparing for Trintellix's U.S. patent expiry with a round of layoffs. | Astellas CEO said he doesn't ...
Sub-Saharan Africa Pharmaceuticals Market OverviewThe Sub-Saharan Africa (SSA) pharmaceuticals market is emerging as one of the fastest-growing healthcare segments, driven by shifting disease patterns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results